5nir Citations

Structural analyses of von Willebrand factor C domains of collagen 2A and CCN3 reveal an alternative mode of binding to bone morphogenetic protein-2.

J Biol Chem 292 12516-12527 (2017)
Cited: 19 times
EuropePMC logo PMID:
doi logo

Abstract

Bone morphogenetic proteins (BMPs) are secreted growth factors that promote differentiation processes in embryogenesis and tissue development. Regulation of BMP signaling involves binding to a variety of extracellular proteins, among which are many von Willebrand factor C (vWC) domain-containing proteins. Although the crystal structure of the complex of crossveinless-2 (CV-2) vWC1 and BMP-2 previously revealed one mode of the vWC/BMP-binding mechanism, other vWC domains may bind to BMP differently. Here, using X-ray crystallography, we present for the first time structures of the vWC domains of two proteins thought to interact with BMP-2: collagen IIA and matricellular protein CCN3. We found that these two vWC domains share a similar N-terminal fold that differs greatly from that in CV-2 vWC, which comprises its BMP-2-binding site. We analyzed the ability of these vWC domains to directly bind to BMP-2 and detected an interaction only between the collagen IIa vWC and BMP-2. Guided by the collagen IIa vWC domain crystal structure and conservation of surface residues among orthologous domains, we mapped the BMP-binding epitope on the subdomain 1 of the vWC domain. This binding site is different from that previously observed in the complex between CV-2 vWC and BMP-2, revealing an alternative mode of interaction between vWC domains and BMPs.

Reviews - 5nir mentioned but not cited (2)

  1. Chen Z, Zhang N, Chu HY, Yu Y, Zhang ZK, Zhang G, Zhang BT. Front Cell Dev Biol 8 593269 (2020)
  2. Quan Y, Li L, Yin Z, Chen S, Yi J, Lang J, Zhang L, Yue Q, Zhao J. Front Pharmacol 12 784335 (2021)

Articles - 5nir mentioned but not cited (4)

  1. Xu ER, Blythe EE, Fischer G, Hyvönen M. J Biol Chem 292 12516-12527 (2017)
  2. Xu ER, von Bülow S, Chen PC, Lenting PJ, Kolšek K, Aponte-Santamaría C, Simon B, Foot J, Obser T, Schneppenheim R, Gräter F, Denis CV, Wilmanns M, Hennig J. Blood 133 366-376 (2019)
  3. Demal TJ, Scholz T, Schüler H, Olfe J, Fröhlich A, Speth F, von Kodolitsch Y, Mir TS, Reichenspurner H, Kubisch C, Hempel M, Rosenberger G. Sci Rep 12 4489 (2022)
  4. Han X, Bai F, Li P, Bai X, Zhang Y, Wang W. Biochem Biophys Rep 37 101647 (2024)


Reviews citing this publication (8)

  1. Perbal B. J Cell Commun Signal 12 3-12 (2018)
  2. Onursal C, Dick E, Angelidis I, Schiller HB, Staab-Weijnitz CA. Front Med (Lausanne) 8 593874 (2021)
  3. Goebel EJ, Hart KN, McCoy JC, Thompson TB. Exp Biol Med (Maywood) 244 1530-1546 (2019)
  4. Migliorini E, Guevara-Garcia A, Albiges-Rizo C, Picart C. Bone 141 115540 (2020)
  5. Sepúlveda V, Maurelia F, González M, Aguayo J, Caprile T. Fluids Barriers CNS 18 45 (2021)
  6. Mehta R, Athar M, Girgis S, Hassan A, Becker RC. J Thromb Thrombolysis 48 14-26 (2019)
  7. Monsen VT, Attramadal H. J Cell Commun Signal 17 371-390 (2023)
  8. Sánchez-Duffhues G, Hiepen C. Cells 12 2200 (2023)

Articles citing this publication (5)

  1. Kaasbøll OJ, Gadicherla AK, Wang JH, Monsen VT, Hagelin EMV, Dong MQ, Attramadal H. J Biol Chem 293 17953-17970 (2018)
  2. Yamada H, Takahashi M, Watanuki M, Watanabe M, Hiraide S, Saijo K, Komine K, Ishioka C. Oncol Lett 21 455 (2021)
  3. Zolfaghari S, Kaasbøll OJ, Monsen VT, Sredic B, Hagelin EMV, Attramadal H. J Biol Chem 299 102803 (2023)
  4. Frampton SL, Sutcliffe C, Baldock C, Ashe HL. Biol Open 11 bio059199 (2022)
  5. Chiappa G, Fassio G, Modica MV, Oliverio M. Toxins (Basel) 16 348 (2024)